Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Dickson

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Oncology Practice|September 4, 2012
Trends in neutropenia-related inpatient eventsChris M Kozma, Michael Dickson, Victoria Chia, et al.
Journal of Managed Care Pharmacy : JMCP|June 24, 2006
Drug and medical cost effects of a drug formulary change with therapeutic interchange for statin drugs in a multistate managed Medicaid organizationBrian Meissner, Michael Dickson, Judy Shinogle, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 5, 2008
Potential drug-drug interactions with antiepileptic drugs in Medicaid recipientsMichael Dickson, Thomas J Bramley, Chris Kozma, et al.
Military Medicine|March 17, 2018
Damage Control Resuscitation Supplemented with Vasopressin in a Severe Polytrauma Model with Traumatic Brain Injury and Uncontrolled Internal HemorrhageJ Michael Dickson, Xu Wang, Alexander E St John, et al.
Clinical Therapeutics|June 20, 2007
Topiramate prescribing patterns among medicaid patients: diagnosis, comorbidities, and dosingSara Poston, Michael Dickson, Michael Johnsrud, et al.
Journal of the South Carolina Medical Association (1975)|December 29, 2012
Physician acceptance of academic detailing for schizophrenia among South Carolina Medicaid providersSarah Ball, Shannon Drayton, Sophie Robert, et al.
International Journal of Cancer|February 11, 2020
End of an era for erythropoiesis-stimulating agents in oncologyMartin W Schoen, Shamia Hoque, Bartlett J Witherspoon, et al.
Journal of Oncology Practice|May 16, 2017
Tale of Two Erythropoiesis-Stimulating Agents: Utilization, Dosing, Litigation, and Costs of Darbepoetin and Epoetin Among South Carolina Medicaid-Covered Patients With Cancer and Chemotherapy-Induced AnemiaVirginia Noxon, Kevin B Knopf, LeAnn B Norris, et al.
Plos One|June 26, 2020
End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemiaShamia Hoque, Brian J Chen, Martin W Schoen, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Oncology Practice|September 4, 2012
Trends in neutropenia-related inpatient eventsChris M Kozma, Michael Dickson, Victoria Chia, et al.
Journal of Managed Care Pharmacy : JMCP|June 24, 2006
Drug and medical cost effects of a drug formulary change with therapeutic interchange for statin drugs in a multistate managed Medicaid organizationBrian Meissner, Michael Dickson, Judy Shinogle, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 5, 2008
Potential drug-drug interactions with antiepileptic drugs in Medicaid recipientsMichael Dickson, Thomas J Bramley, Chris Kozma, et al.
Military Medicine|March 17, 2018
Damage Control Resuscitation Supplemented with Vasopressin in a Severe Polytrauma Model with Traumatic Brain Injury and Uncontrolled Internal HemorrhageJ Michael Dickson, Xu Wang, Alexander E St John, et al.
Clinical Therapeutics|June 20, 2007
Topiramate prescribing patterns among medicaid patients: diagnosis, comorbidities, and dosingSara Poston, Michael Dickson, Michael Johnsrud, et al.
Journal of the South Carolina Medical Association (1975)|December 29, 2012
Physician acceptance of academic detailing for schizophrenia among South Carolina Medicaid providersSarah Ball, Shannon Drayton, Sophie Robert, et al.
International Journal of Cancer|February 11, 2020
End of an era for erythropoiesis-stimulating agents in oncologyMartin W Schoen, Shamia Hoque, Bartlett J Witherspoon, et al.
Journal of Oncology Practice|May 16, 2017
Tale of Two Erythropoiesis-Stimulating Agents: Utilization, Dosing, Litigation, and Costs of Darbepoetin and Epoetin Among South Carolina Medicaid-Covered Patients With Cancer and Chemotherapy-Induced AnemiaVirginia Noxon, Kevin B Knopf, LeAnn B Norris, et al.
Plos One|June 26, 2020
End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemiaShamia Hoque, Brian J Chen, Martin W Schoen, et al.
Pageof 2